
Uniglip PM 2mg/500mg/15mg Tablet SR
Marketer
Unimarck Healthcare Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Uniglip PM 2mg/500mg/15mg Tablet SR
Glycipan SR 2mg/500mg/15mg tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, enhances blood sugar control in adults with type 2 diabetes. It improves insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and frequency; take with food to prevent indigestion. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling up. An overdose can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal discomfort, headache, bone fractures, and respiratory infections. Consult your physician before use if you have kidney, liver, or heart issues, or if you are pregnant or breastfeeding. Kidney function tests are typically performed before treatment commences. Limit alcohol consumption to minimize potential side effects.
Primary Ingredients of Uniglip PM 2mg/500mg/15mg Tablet SR
No information provided. Therefore, no text can be rewritten.
Uses of Uniglip PM 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Uniglip PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Uniglip PM 2mg/500mg/15mg SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
Common Side effects of Uniglip PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Uniglip PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Uniglip PM 2mg/500mg/15mg sustained-release tablet should be taken with a meal.
How Uniglip PM 2mg/500mg/15mg Tablet SR works:
Uniglip PM 2mg/500mg/15mg Extended-Release tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions. This triple combination improves blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Uniglip PM 2mg/500mg/15mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Uniglip PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Uniglip PM 2mg/500mg/15mg SR tablets while breastfeeding is likely inadvisable. Available data in humans indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Uniglip PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. In cases of severe kidney disease, this medication is contraindicated. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Uniglip PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Uniglip PM 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Uniglip PM 2mg/500mg/15mg Tablet SR :
Should you forget to take your Uniglip PM 2mg/500mg/15mg Tablet SR, administer the dose as soon as you remember. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Uniglip PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
